During the past decade, Peninsula Cancer Institute-Gloucester conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peninsula Cancer Institute-Gloucester" #1 sponsor was "National Cancer Institute (NCI)" with 12 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored, "NRG Oncology" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peninsula Cancer Institute-Gloucester" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Peninsula Cancer Institute-Gloucester" are "Invasive Breast Carcinoma" (5 trials), "Anatomic Stage II Breast Cancer AJCC v8" (3 trials), "Breast Adenocarcinoma" (3 trials), "Prognostic Stage II Breast Cancer AJCC v8" (3 trials) and "Anatomic Stage IIA Breast Cancer AJCC v8" (2 trials). Many other conditions were trialed in "Peninsula Cancer Institute-Gloucester" in a lesser frequency.

Most popular intervention types in "Peninsula Cancer Institute-Gloucester" are "Drug" (20 trials), "Other" (19 trials), "Biological" (11 trials), "Procedure" (5 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (13 trials), "Laboratory Biomarker Analysis" (9 trials), "Paclitaxel" (7 trials), "Doxorubicin Hydrochloride" (6 trials) and "Questionnaire Administration" (6 trials). Other intervention names were less common.

The vast majority of trials in "Peninsula Cancer Institute-Gloucester" are 17 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Peninsula Cancer Institute-Gloucester". undefined are not yet recruiting, 9 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Peninsula Cancer Institute-Gloucester, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Peninsula Cancer Institute-Gloucester, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".